WAYS TO SUPPORT MY WORK ⬇️
💊 OVER THE COUNTER ORAL PEPTIDE SUPPLIMENTS: 
BPC-157 // Can’t Weight // TB4-FRAG // KPV 
Sign up here and use code “OTP10” to save 10% 
https://integrativepeptides.com/OTP
WHY I TRUST INTEGRATIVE PEPTIDES: 
🇺🇸 Made in the USA 
📋 CGMP Compliant (FDA oversight of their products) 
🧑‍⚕️Trusted and Sold By Doctors and Clinics all over the USA
📕 GET MY BOOK! 
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp 
https://amzn.to/4gAXrz4
SOCIALS: 
📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx 
🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&amp;_r=1 
👾: https://discord.gg/ZHeUh7WV 
📺: https://youtube.com/@ManOnTheMounjaro?feature=shared 
❌: https://x.com/manonthepen?s=21 
💻: https://www.onthepen.com

In this powerful interview, Noom CEO Geoff Cook opens up about his mission to bring down the cost of GLP-1 medications like Ozempic, Wegovy, and Zepbound—and why he believes compounding pharmacies could play a critical role in making these life-changing drugs more accessible. We dig into the failures of the U.S. healthcare system, how the Trump-era Most Favored Nation policy aimed to fight high drug prices, and why patients are still paying thousands out of pocket. If you care about affordable access to GLP-1s, compounded semaglutide, or the future of obesity care, this conversation is a must-watch.

Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad